What is ClearPoint Neuro?
ClearPoint Neuro Inc. is a medical device company dedicated to advancing minimally invasive surgical procedures within the brain. Its core offerings include sophisticated navigation and delivery systems that facilitate precise targeting and real-time MRI guidance for neurosurgical interventions. The company's technology supports a range of critical applications, such as deep brain stimulation, laser ablation, biopsy procedures, and targeted drug delivery, all aimed at treating complex neurological conditions. By enhancing surgical accuracy and improving patient outcomes, ClearPoint Neuro is expanding treatment options for challenging brain disorders, serving neurosurgeons and medical institutions with cutting-edge tools for image-guided neurosurgery.
How much funding has ClearPoint Neuro raised?
ClearPoint Neuro has raised a total of $180.5M across 6 funding rounds:
Debt
$1.3M
Debt
$350K
Debt
$7.5M
Stock Offering
$43.4M
Other Financing Round
$110M
Private Equity
$17.9M
Debt (2011): $1.3M, investors not publicly disclosed
Debt (2020): $350K led by PPP
Debt (2020): $7.5M supported by Petrichor Healthcare Capital Management
Stock Issuance/Offering (2021): $43.4M, investors not publicly disclosed
Other Financing Round (2025): $110M backed by Oberland Capital
Private Equity (2026): $17.9M, investors not publicly disclosed
Key Investors in ClearPoint Neuro
Oberland Capital
Oberland Capital is a private investment firm focused on funding innovation in the global healthcare industry, managing approximately $3 billion in assets. The firm specializes in flexible investment structures tailored to meet the specific needs of its partners, offering a range of financing solutions including monetization of royalty streams and project-based financing.
What's next for ClearPoint Neuro?
The recent major enterprise-level funding and strategic investment signal a pivotal phase for ClearPoint Neuro. This capital infusion is likely to accelerate the company's research and development efforts, potentially leading to the commercialization of next-generation neurosurgical technologies. Strategic partnerships and market expansion are anticipated as the company leverages this financial backing to solidify its position in the competitive neurosurgery landscape. The company's focus on precision and image guidance suggests a trajectory towards becoming a leader in advanced neurological treatments.
See full ClearPoint Neuro company page
